Updates on Device-Based Therapies for Patients with Heart Failure

被引：9

作者：

Al Danaf J. ^{[1
]}

Butler J. ^{[2
]}

Yehya A. ^{[3
]}

机构：

[1] Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, 30 N. 1900E, Room 4A100, Salt Lake City, 84112, UT

[2] Division of Cardiovascular Medicine, Department of Internal Medicine, University of Mississippi, 2500 N State Street L650, Jackson, 39216, MS

[3] Division of Cardiovascular Medicine, Department of Internal Medicine, Augusta University, 95 Collier Rd Suite 3000, Atlanta, 30309, GA

来源：

Current Heart Failure Reports | 2018年 / 15卷 / 2期

基金：

美国国家卫生研究院;

关键词：

Clinical trials; CRT-D; Device-based therapies; Heart failure reduced ejection fraction; Hemodynamic monitoring; LVAD;

D O I：

10.1007/s11897-018-0384-x

中图分类号：

学科分类号：

摘要：

Purpose of Review: Heart failure is a growing epidemic. Optimal medical therapy remains the cornerstone of heart failure management but device-based therapies have been shown to contribute to morbidity and mortality reduction. Recent Findings: Multiple investigational trials had been conducted in the past decade that helped us better understand and manage heart failure. In this manuscript, we will discuss the major device related trials of year 2017 in the fields of defibrillators, hemodynamic monitoring, remote monitoring, autonomic nervous system modulation, ventricular assist devices, and device-based valvular heart disease management. Summary: Further research and trials in device-based therapies are needed to explore their long-term reduction in mortality and morbidity along with cost-effectiveness analyses in patients living with heart failure. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

引用

页码：53 / 60

页数：7

共 56 条

[1]

Hunt S.A., Abraham W.T., Chin M.H., Et al., 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation, J Am Coll Cardiol, 53, pp. e1-e90, (2009)

[2]

Askoxylakis V., Thieke C., Pleger S.T., Most P., Tanner J., Lindel K., Et al., Long-term survival of cancer patients compared to heart failure and stroke: a systematic review, BMC Cancer, 10, (2010)

[3]

Ross J.S., Chen J., Lin Z., Bueno H., Curtis J.P., Keenan P.S., Et al., Recent national trends in readmission rates after heart failure hospitalizations, Circ Heart Fail, 3, pp. 97-103, (2010)

[4]

Hummel S.L., Pauli N.P., Krumholz H.M., Wang Y., Chen J., Normand S.L., Et al., Thirty-day outcomes in Medicare patients with heart failure at heart transplant centers, Circ Heart Fail, 3, pp. 244-252, (2010)

[5]

Heidenreich P.A., Albert N.M., Allen L.A., Bluemke D.A., Butler J., Fonarow G.C., Et al., American Heart Association advocacy coordinating committee

[6]

council on arteriosclerosis, thrombosis and vascular biology

[7]

council on cardiovascular radiology and intervention

[8]

council on clinical cardiology

[9]

council on epidemiology and prevention

[10]

stroke council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association, Circ Heart Fail., 6, pp. 606-619, (2013)

← 1 2 3 4 5 6 →